News | News By Subject | News by Disease News By Date | Search News

Investor (World) News

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Buy Vertex (VRTX) Now for $45B Or Risk It All, Analyst Tells Gilead (GILD)     4/24/2015
Ipsen (IPN.PA), Active Biotech AB (BTPC) Plummet As Prostate Cancer Drug Flunks Late-Stage Trial     4/17/2015
“Batten Down the Hatches” But Look For Opportunity in Rough First Quarter, Says Analyst     4/8/2015
Teva (TEVA)'s Recent Moves Suggest Restructuring Will Focus on Hypertension, Respiratory & CNS Markets     4/6/2015
Analyst: A Complete List of All Major Biosimilars Could Be the A to Z Guide     4/6/2015
Amgen (AMGN) in the Crosshairs As Biogen (BIIB), Hospira, Merck & Co. (MRK) All Climb on Biosimilar Bandwagon: Citi     4/2/2015
MorphoSys AG Tanks 20% on Celgene (CELG) Cancer Pact Breakup News     3/30/2015
Analyst: First Quarter Market Meltdown Just "Clockwork," As Biogen (BIIB), Celgene (CELG) Reign     3/27/2015
CAR-T, Checkpoint Inhibitors and Vaccines All Key at Crucial Conference, Says Cowen and Company     3/27/2015
BioPharm Executive: Why Your Last Investment Blew Up     3/26/2015
Biogen (BIIB) Slides For Alzheimer's Drug Wow Analysts, Set Up Fight for Eli Lilly (LLY)     3/23/2015
MS Specialist Picks Biogen Idec (BIIB)’s Tecfidera and Plegridy, Teva (TEVA)’s Laquinimod: Analyst     3/17/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
AbbVie (ABBV) Overpaid in Pharmacyclics (PCYC) Deal, For Only 50% Rights to Imbruvica: Analyst     3/6/2015
Analyst: Docs Bullish On Roche (RHHBY)'s Perjeta and PD-1/PDL1, Cautious on Palbociclib and Neratinib     3/5/2015

Featured Stories
Traders’ Infatuation With Ebola Drugs Causing “Rollercoaster” Market, Says Tekmira (TKMR) CEO     10/8/2014
Move Over San Francisco: Boston Showing Its Pharmaceutical Potential     8/26/2014
5 Ways to Spot the Next Hot Biotech Stock     6/22/2012
New Hope For Javelin Pharmaceuticals (JAV)'s Pain Candidate But Safety Concerns Remain     2/26/2010
Merck & Co., Inc. (MRK): Potential Remains For HIV Drug Despite Trial Disappointment     2/2/2010
Roche: Novel Herceptin Formulation Promises Greater Convenience     1/22/2010
US and EU Regulators Close in on Pharmaceutical Pay-for-delay Deals     1/19/2010
Big Pharma Seeks to Insulate Itself from Impact of Patent Cliff     11/20/2009
BioPharm Executive: Vivus: Savior of the Pharma Industry?     9/30/2009
BioPharm Executive: Biotech's Dog Days     8/26/2009
BioPharm Executive: Sunshine, Lollipops, and Exclusivity     7/21/2009
BioPharm Executive: Sprinting to the Finish     6/30/2009
What the CEOs See: Four Biotech Leaders on the Recession, Venture Capital, and How Their Industry Can Help Lead Massachusetts into a Recovery     5/20/2009
Job Market Brutal, but Good Biotech Entrepreneurs Still Hard to Find     5/14/2009
BioPharm Executive: We Are All Activists Now     4/29/2009
Novogen Limited (NVGN) Regains Full Compliance With NASDAQ Listing Rule     4/28/2015
GW Pharmaceuticals (GWPH) Announces Proposed Public Offering Of ADSs     4/28/2015
China Cord Blood Corporation Receives $512 Million Take-Private Offer     4/28/2015
Syngenta AG (SYT) Annual General Meeting     4/28/2015
ERYtech Pharma Receives The EnterNext Tech 40 Label     4/28/2015
Innocoll, Inc. (INNL) Announces Pricing Of Follow-On Offering     4/24/2015
Nordic Nanovector – Share Capital Increase Registered     4/24/2015
Change In BioTie Therapies Corp.' Financial Calendar 2015     4/23/2015
Change In The Number Of Votes Relating To BioTie Therapies Corp.'s Shares     4/23/2015
The Nomination Committee’s Proposals To The Annual General Meeting In Karo Bio AB     4/23/2015
Horizon Pharma (HZNP) Announces Closing Of Public Offering Of Ordinary Shares And Full Exercise Of Underwriters' Option To Purchase Additional Shares     4/23/2015
Tiziana Life Sciences Plc Release: Issue Of Convertible Loan Notes And Warrants     4/22/2015
Annual General Meeting In BioInvent (BOVNF)     4/22/2015
Foamix Pharmaceuticals, Ltd. (FOMX) Announces Closing Of Its $69 Million Public Offering Of Ordinary Shares     4/20/2015
Admedus Completes Fully Subscribed $16.1 Million Rights Issue     4/17/2015

More News
No News Posted on that date

Career Tips
Sucampo (SCMP) Looks to Add to "Scientific Core" As Global Reach Grows, Says HR     4/16/2015
8 Things That are Hurting Your Resume     4/16/2015
8 Ways to Increase Your Paycheck     4/16/2015
Flexion (FLXN) CEO Discusses Pipeline and Jobs     4/3/2015
What Employers Think When They See Your LinkedIn Profile     4/2/2015
Five Ways to Build Rapport With Your Interviewer     4/2/2015
Relypsa (RLYP) Hits the Big Leagues: New Hires in Almost Every Department     3/19/2015
Four Common Job Applicant Weaknesses     3/19/2015
Three Resume Secrets Professionals Swear By     3/19/2015
Booming PTC Therapeutics (PTCT) Means Job Openings     3/5/2015
Most Frequent Post-Job Interview Mistake     3/5/2015
Five Employer Concerns Every Job Applicant Must Address     3/5/2015
HR Exec Reveals In-Demand Jobs at MyoKardia     2/19/2015
Pfizer (PFE) Buy Means Jobs: Make Sure Your References Are an Asset     2/19/2015
7 Job Search Sins     2/19/2015

Other News Sources
//-->